C. Knechtli

Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia

C. Knechtli, Nicholas J. Goulden, Jeremy Hancock et al. · Blood · 1998 · 256 citations

Medicine, Hematology, Pediatrics +17

Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemia

C. Knechtli, Nicholas J. Goulden, Jeremy Hancock et al. · British Journal of Haematology · 1998 · 111 citations

Medicine, Hematology, Immunology +16

Minimal residual disease analysis for the prediction of relapse in children with standard‐risk acute lymphoblastic leukaemia

Nicholas J. Goulden, C. Knechtli, Russell J. Garland et al. · British Journal of Haematology · 1998 · 101 citations · Full text

Medicine, Hematology, Pediatrics +17

Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia.

D I Marks, Jennifer M. Bird, Jacqueline Cornish et al. · Journal of Clinical Oncology · 1998 · 73 citations

Medicine, Hematology, Pediatrics +17

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With <i>NPM1</i> and <i>FLT3</i> Mutations

Nigel H. Russell, Charlotte S. Wilhelm-Benartzi, Jad Othman et al. · Journal of Clinical Oncology · 2024 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15